Date: September 14, 2023
Time: 11:00 AM (PST), 2:00 PM (EST), 8:00 PM (CET)
In the United States, over 40,000 transplantations are performed annually. Ensuring post-transplant success requires diligent monitoring of infectious diseases that are associated with a wide range of pathology including organ graft failure and death. CMV and EBV are opportunistic viruses with high prevalence. Infections from these viruses can be asymptomatic or in some cases may cause mild symptoms in immunocompetent individuals but can lead to significant complications in those who are immunocompromised e.g. patients post-transplant. For this reason, post-transplantation monitoring of CMV and EBV viral load plays an important role in the management of transplant recipients.
- Clinical review of the CMV and EBV disease landscape
- Discuss the importance of accurate quantitation of transplant viral load markers and impact to patient care
- Assess laboratory workflow considerations for transplant viral load markers
- Evaluate performance of Alinity m CMV and EBV viral load assays
Webinars will be available for on-demand viewing for 24 months after broadcast.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.